PPARA and metabolic dysfunction-associated steatohepatitis: In this study, the expression of PPARα was significantly reduced in NAFL and NASH mice compared to the NC group; however, Ganweikang tablet partially reversed this effect (Figure 7E and Supplementary Figure S1E), suggesting that Ganweikang tablet could increase FAO levels in the liver of NAFLD model mice.